The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
-
- T. Zuberbier
- Charité—Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt‐Universität zu Berlin, and Berlin Institute of Health Department of Dermatology and Allergy Allergy‐Centre‐Charité Berlin Germany
-
- W. Aberer
- Department of Dermatology Medical University of Graz Graz Austria
-
- R. Asero
- Department of Allergology Clinica San Carlo Paderno Dugnano MI Italy
-
- A. H. Abdul Latiff
- Allergy& Immunology Centre Pantai Hospital Kuala Lumpur Kuala Lumpur Malaysia
-
- D. Baker
- Baker Allergy Asthma and Dermatology Clinic Portland OR USA
-
- B. Ballmer‐Weber
- Allergy Unit Department of Dermatology University Hospital Zürich Switzerland
-
- J. A. Bernstein
- University of Cincinnati Physicians Immunology Research Center Cincinnati OH USA
-
- C. Bindslev‐Jensen
- Department of Dermatology and Allergy Centre Odense University Hospital and University of Southern Denmark Odense Denmark
-
- Z. Brzoza
- Department of Internal Diseases, Allergology and Clinical Immunology in Katowice Medical University of Silesia Katowice Poland
-
- R. Buense Bedrikow
- Santa Casa de Sao Paulo School of Medical Sciences Sao Paulo Brazil
-
- G. W. Canonica
- Personalized Medicine Asthma and Allergy Clinic‐Humanitas University & Research Hospital Milano Italy
-
- M. K. Church
- Charité—Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt‐Universität zu Berlin, and Berlin Institute of Health Department of Dermatology and Allergy Allergy‐Centre‐Charité Berlin Germany
-
- T. Craig
- Department of Medicine and Pediatrics Penn State University Hershey Medical Center Hershey PA USA
-
- I. V. Danilycheva
- National Research Center—Institute of Immunology Federal Medical‐Biological Agency of Russia Moscow Russia
-
- C. Dressler
- Charité—Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt‐Universität zu Berlin, and Berlin Institute of Health Division of Evidence Based Medicine Department of Dermatology Berlin Germany
-
- L. F. Ensina
- Federal University of Sao Paulo Sao Paulo Brazil
-
- A. Giménez‐Arnau
- Hospital del Mar IMIM Universitat Autònoma Barcelona Barcelona Spain
-
- K. Godse
- Department of Dermatology Dr. D. Y. Patil Medical College & Hospital Nerul Navi Mumbai India
-
- M. Gonçalo
- Clinic of Dermatology Faculty of Medicine and University Hospital Coimbra Portugal
-
- C. Grattan
- St John's’ Institute of Dermatology Guy's’ and St. Thomas’ Hospital NHS Foundation Trust London UK
-
- J. Hebert
- Service d'allergie Centre Hospitalier Université Laval/Centre Hospitalier Universitaire de Québec Québec QC Canada
-
- M. Hide
- Department of Dermatology Institute of Biomedical and Health Sciences Hiroshima University Hiroshima Japan
-
- A. Kaplan
- Department of Medicine Division of Pulmonary and Critical Care Medicine Allergy and Clinical Immunology Medical University of South Carolina Charleston SC USA
-
- A. Kapp
- Department of Dermatology and Allergy Hannover Medical School Hannover Germany
-
- C. H. Katelaris
- Campbelltown Hospital and Western Sydney University Sydney Australia
-
- E. Kocatürk
- Department of Dermatology Okmeydani Training and Research Hospital Istanbul Turkey
-
- K. Kulthanan
- Department of Dermatology Faculty of Medicine Siriraj Hospital Mahidol University Bangkok Thailand
-
- D. Larenas‐Linnemann
- Hospital Médica Sur Mexico City Mexico
-
- T. A. Leslie
- Royal Free Hospital London UK
-
- M. Magerl
- Charité—Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt‐Universität zu Berlin, and Berlin Institute of Health Department of Dermatology and Allergy Allergy‐Centre‐Charité Berlin Germany
-
- P. Mathelier‐Fusade
- Department of Dermatology and Allergy University Hospital of Tenon Paris France
-
- R. Y. Meshkova
- Department of Clinical Immunology and Allergy Smolensk State Medical University Smolensk Russia
-
- M. Metz
- Charité—Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt‐Universität zu Berlin, and Berlin Institute of Health Department of Dermatology and Allergy Allergy‐Centre‐Charité Berlin Germany
-
- A. Nast
- Charité—Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt‐Universität zu Berlin, and Berlin Institute of Health Division of Evidence Based Medicine Department of Dermatology Berlin Germany
-
- E. Nettis
- Scuola e Cattedra di Allergologia e Immunologia Clinica Dipartimento dell'Emergenza e dei Trapianti d'Organo Università di Bari Bari Italy
-
- H. Oude‐Elberink
- University of Groningen Groningen The Netherlands
-
- S. Rosumeck
- Charité—Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt‐Universität zu Berlin, and Berlin Institute of Health Division of Evidence Based Medicine Department of Dermatology Berlin Germany
-
- S. S. Saini
- Johns Hopkins Asthma and Allergy Center Baltimore MD USA
-
- M. Sánchez‐Borges
- Allergy and Clinical Immunology Department Centro Médico‐Docente La Trinidad Caracas Venezuela
-
- P. Schmid‐Grendelmeier
- Allergy Unit Department of Dermatology University Hospital Zürich Switzerland
-
- P. Staubach
- Department of Dermatology University Medical Center Mainz Mainz Germany
-
- G. Sussman
- Division of Allergy and Clinical Immunology University of Toronto Toronto ON Canada
-
- E. Toubi
- Bnai‐Zion Medical Center Faculty of Medicine Technion Haifa Israel
-
- G. A. Vena
- Dermatology and Venereology Private Practice Bari and Barletta Italy
-
- C. Vestergaard
- Department of Dermatology and Venereology Aarhus University Hospital Aarhus Denmark
-
- B. Wedi
- Department of Dermatology and Allergy Hannover Medical School Hannover Germany
-
- R. N. Werner
- Charité—Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt‐Universität zu Berlin, and Berlin Institute of Health Division of Evidence Based Medicine Department of Dermatology Berlin Germany
-
- Z. Zhao
- Department of Dermatology and Venereology Peking University First Hospital Beijing China
-
- M. Maurer
- Charité—Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt‐Universität zu Berlin, and Berlin Institute of Health Department of Dermatology and Allergy Allergy‐Centre‐Charité Berlin Germany
抄録
<jats:title>Abstract</jats:title><jats:p>This evidence‐ and consensus‐based guideline was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (<jats:styled-content style="fixed-case">GRADE</jats:styled-content>) working group. The conference was held on 1 December 2016. It is a joint initiative of the Dermatology Section of the European Academy of Allergology and Clinical Immunology (<jats:styled-content style="fixed-case">EAACI</jats:styled-content>), the <jats:styled-content style="fixed-case">EU</jats:styled-content>‐founded network of excellence, the Global Allergy and Asthma European Network (<jats:styled-content style="fixed-case">GA</jats:styled-content>²<jats:styled-content style="fixed-case">LEN</jats:styled-content>), the European Dermatology Forum (<jats:styled-content style="fixed-case">EDF</jats:styled-content>) and the World Allergy Organization (<jats:styled-content style="fixed-case">WAO</jats:styled-content>) with the participation of 48 delegates of 42 national and international societies. This guideline was acknowledged and accepted by the European Union of Medical Specialists (<jats:styled-content style="fixed-case">UEMS</jats:styled-content>). Urticaria is a frequent, mast cell‐driven disease, presenting with wheals, angioedema, or both. The lifetime prevalence for acute urticaria is approximately 20%. Chronic spontaneous urticaria and other chronic forms of urticaria are disabling, impair quality of life and affect performance at work and school. This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomechanisms. In addition, it outlines evidence‐based diagnostic and therapeutic approaches for the different subtypes of urticaria.</jats:p>
収録刊行物
-
- Allergy
-
Allergy 73 (7), 1393-1414, 2018-06-25
Wiley
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1360285710446423168
-
- ISSN
- 13989995
- 01054538
-
- データソース種別
-
- Crossref
- KAKEN